+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Diagnostics - Global Market Trajectory & Analytics

  • ID: 4806349
  • Report
  • February 2022
  • Region: Global
  • 548 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies
  • Bio SB
  • Bio-Genex Laboratories
  • F. Hoffmann-La Roche Ltd

Global Tissue Diagnostics Market to Reach $4.8 Billion by 2024


Tissue diagnostics is the process of testing and analysis of tissue samples by way of capturing diseases` biological context. The tests are mainly used for detecting medical conditions such as inflammatory disorders and cancers for revealing the right type of disease and also its malignancy level, which is essential for determining the right treatment options. Amid the COVID-19 crisis, the global market for Tissue Diagnostics is projected to reach US$4.8 Billion by 2024, registering a compounded annual growth rate (CAGR) of 5.6% over the analysis period. United States represents the largest regional market for Tissue Diagnostics, accounting for an estimated 34.9% share of the global total. The market is projected to reach US$1.7 Billion by the close of the analysis period. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 8.7% over the analysis period.Growth in the global market is set to be fueled by increase in cancer incidences, aging population and increasing healthcare spending by countries. General increase in diagnostic test numbers, technology advancements and increasing pharma industry investments are the other important factors behind strong growth for the global market for tissue diagnostics. Tissue diagnostics is emerging as one of the important tools for cancer management. Tissue diagnosis for cancer detection is carried out through core biopsy, fine needle aspiration cytology and open biopsy. North America represents a key regional market, led by factors such as higher cancer incidence rate, growth of personalized medicine, increased adoption of technologically more advanced tissue diagnostics, geriatric population, and high number of collaborations between biotech firms and pharmaceutical companies in the region. Growth in the Asia-Pacific region is attributable to the constantly rising need for enhanced testing, increased demand for improved facilities for patient care, and favorable regulations.

The market for Immunohistochemistry tissue diagnostic tests is forecast to dominate market share over the analysis period. IHC is applied widely in development of diagnostics as well as therapeutics for cancers and also in clinical R&D. The test is being increasingly preferred to traditional enzyme-staining techniques. Continuous innovations also create strong growth opportunities for the market. Technical advances in IHC technique have the potential to harness the wealth of contextual information contained in tissue samples. To meet the demand for precise and accurate data, next-generation IHC techniques improve the accuracy, precision, and analytical features to expedite research and improve patient care.

Select Competitors (Total 40 Featured) -

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio SB
  • Bio-Genex Laboratories
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • QIAGEN N.V.
  • Sakura Finetek Japan Co., Ltd.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies
  • Bio SB
  • Bio-Genex Laboratories
  • F. Hoffmann-La Roche Ltd

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Tissue Diagnostics Market: Prelude
  • Immunohistochemistry Emerges as the Major Tissue Diagnostic Test
  • Breast Cancer Leads the Application Market for Tissue Diagnostics
  • Hospitals Represent the Leading End-Use Segment
  • Developed Regions Lead, Developing Economies to Spearhead Growth
  • Impact of COVID-19 on Healthcare & Pharmaceutical Industries
  • Competition
  • Recent Market Activity
  • Tissue Diagnostics – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Rising Cancer Incidence Worldwide Spurs Demand for Tissue Diagnostics
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
  • Global Number of New Cancer Cases (in Million) in Men by Cancer Site: 2018
  • Global Number of New Cancer Deaths (in Million) in Men by Cancer Site: 2018
  • Global Number of New Cancer Cases (in Million) in Women by Cancer Site: 2018
  • Global Number of New Cancer Deaths (in Million) in Women by Cancer Site: 2018
  • Aging Population and Changing Lifestyles Drive Cancer Incidence, Fueling Prospects for Tissue Diagnostics Market
  • Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
  • Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Global Cancer Deaths by Age Group (in %) for 2019
  • Increasing Healthcare Spending Levels Augur Well for the Market
  • Global Healthcare Market Size in $ Billion for the Years 2018-2022
  • Healthcare Expenditure as a % of GDP by Region for 2019
  • Per Capita Healthcare Spending (in $) in Select Countries for the Year 2019
  • Growing Significance of Personalized Medicine: An Opportunity for Tissue Diagnostics Market
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
  • Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting Therapy Decisions in NSCLCs
  • Sustained Advancements in Tissue Diagnostics Space Fuel Market Prospects
  • Market Poised to Benefit from Digitalization of Tissue Diagnostic Techniques & Automated Tissue Diagnostic Systems

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 40
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio SB
  • Bio-Genex Laboratories
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • QIAGEN N.V.
  • Sakura Finetek Japan Co., Ltd.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown